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Renal transplantation from
HLA-haploidentical living-related donors: the
effects of donor-specific blood transfusions
and different immunosuppressive regimens.∗
Kenichi Sakagami, Shinya Saito, Shigehiro Shiozaki, Takuzo Fujiwara, Minoru
Haisa, Takefumi Niguma, Satoshi Kusaka, Masashi Uda, Tsuyoshi Matsuno,
Shinji Takasu, Mehmet Ali Yerdel, Junji Matsuoka, Shinichiro Tanaka, and
Kunzo Orita
Abstract
One-hundred-nine HLA-haploidentical living related renal transplants have been retrospec-
tively analysed to compare the effect of donor-specific blood transfusion (DST) and different im-
munosuppressive regimens on graft survival and acute rejection. The recipients were divided into
four groups according to the immunosuppressive therapy. Group 1 (n = 44): conventional therapy
with posttransplant azathioprine (AZP) + methylprednisolone (MP). Group 2 (n = 25): pretrans-
plant DST + posttransplant AZP + MP. Group 3 (n = 12): triple-drug therapy with posttransplant
AZP + MP + cyclosporine (CS). Group 4 (n = 25): pretransplant DST + posttransplant AZP +
MP + CS. The five-year actuarial survival rates for groups 1, 2, 3 and 4 were 48%, 73%, 79%,
and 89%, respectively. The graft survival rate in group 3 was significantly (p less than 0.01) better
than that in group 1. The transfusion effect was reduced, and appears as a 10% improvement in
the graft survival in the cyclosporin era compared with a 25% improvement at pre-cyclosporin era.
Furthermore, the incidence of the first rejection episode was decreased in recipients that received
DST. The present study revealed that DST, as pretransplant conditioning has a definite impact on
rejection-free long-term graft survival in HLA-haploidentical living-related kidney recipients and
the most favorable outcome in such patients could be achieved by DST pretreatment in conjunction
with posttransplant triple-drug therapy including cyclosporine.
KEYWORDS: living-related kindney transplantation, donor-specific blood transfusion (DST),
cyclosporine
∗PMID: 1561899 [PubMed - indexed for MEDLINE]
Copyright (C) OKAYAMA UNIVERSITY MEDICAL SCHOOL
1Sakagami et al.: Renal transplantation from HLA-haploidentical living-related
Produced by The Berkeley Electronic Press, 1992
2Acta Medica Okayama, Vol. 46 [1992], Iss. 1, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol46/iss1/2
3Sakagami et al.: Renal transplantation from HLA-haploidentical living-related
Produced by The Berkeley Electronic Press, 1992
4Acta Medica Okayama, Vol. 46 [1992], Iss. 1, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol46/iss1/2
5Sakagami et al.: Renal transplantation from HLA-haploidentical living-related
Produced by The Berkeley Electronic Press, 1992
